pocketful logo
Lotus Eye Hospital & Institute Ltd logo

Lotus Eye Hospital & Institute Ltd

NSE: LOTUSEYE BSE: 532998

98.22

(-4.38%)

Wed, 01 Apr 2026, 08:05 pm

Lotus Eye Hospital & Institute Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    210.77

  • Net Profit

    0.74

  • P/B

    2.42

  • Sector P/E

    71.13

  • P/E

    194.17

  • EV/EBITDA

    29.70

  • Debt/Equity (Industry)

    0.48

  • Interest Cover (Industry)

    6.53

  • ROCE (Industry)

    15.74

  • RONW (Industry)

    16.96

  • ROE

    1.24

  • ROCE

    2.99

  • Debt/Equity

    0.04

  • EPS (TTM)

    0.31

  • Dividend Yield

    0

  • Book Value

    29.15

  • Interest Cover

    3.88

Analysis

all

thumbs up icon

Pros

  • Lotus Eye Hospital and Institute is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Lotus Eye Hospital and Institute is profitable, therefore cash runway is not a concern.
  • Lotus Eye Hospital and Institute is profitable, therefore cash runway is not a concern.
  • Lotus Eye Hospital and Institute has no debt, it does not need to be covered by operating cash flow.
  • Lotus Eye Hospital and Institute has no debt, it does not need to be covered by short term assets.
thumbs up icon

Cons

  • Unable to calculate sustainability of dividends as Lotus Eye Hospital and Institute has not reported any payouts.
  • Unable to evaluate Lotus Eye Hospital and Institute's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Lotus Eye Hospital and Institute's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • High level of physical assets or inventory.
  • Lotus Eye Hospital and Institute is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters40.6740.6440.3940.2240.14
FII0.010.00000
DII0.020.020.020.040.04
Public59.3159.3359.5959.7459.82
Government00000

Read More

Technical Analysis

RSI

42.65

MACD

-3.44

50 DMA

114.44

200 DMA

106.10

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic133.92118.44108.33102.9692.8587.4872.00
Fibonacci118.44112.53108.87102.9697.0593.3987.48
Camarilla102.48101.0699.64102.9696.8095.3893.96

Pivots Level: Classic

R3

+30.96

133.92

R2

+15.48

118.44

R1

+5.37

108.33

102.96
102.96
Pivot Point
LTP: 101.84

S1

-10.11

92.85

S2

-15.48

87.48

S3

-30.96

72.00

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    103.69

  • 20-EMA

    106.30

  • 30-EMA

    108.46

  • 50-EMA

    111.15

  • 100-EMA

    111.95

  • 200-EMA

    105.59

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 Feb 2026board-meetingsQuarterly Results
12 Nov 2025board-meetingsQuarterly Results
29 Aug 2025agm
22 Jul 2024agm
01 Sept 2023agm
18 Aug 2023agmAnnual General Meeting19 Sept 2023
18 Aug 2023dividendDividend - Re 0.50 Per Share18 Sept 2023
24 May 2023dividend₹0.50 Dividend /Share18 Sept 2023
01 Sept 2022agm
10 Aug 2022dividendFinal Dividend - Rs. - 0.510 Sept 2022

Read More

Peer Comparison

Lotus Eye Hospital & Institute Ltd logo

Lotus Eye Hospital & Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Read More

Lotus Eye Hospital & Institute Ltd About

Lotus Eye Hospital & Institute sengagedinthefieldofophthalmology(Eye)anditsrelatedoperations.

Industry

Healthcare

Founded

1997

Headquarters

CEO

Kaveetha Sundaramoorthy

Employees

Contact

Website icon

Website

http://www.lotuseye.org

Email icon

Email

lotussecdept@gmail.com

Phone icon

Phone

91-0422 4229900

Location icon

Location

SF No770/12 Civil Aerodrome(P), Avinashi Road, Coimbatore, Tamil Nadu, 641014

Read More

Lotus Eye Hospital & Institute Ltd Company History

YearHistory
2009
  • Mr. R Subramanian, Chartered Accountant, Chennai was appointed as Additional Director of the company.
2012
  • Mr. G. R. Karthikeyan and Mr. M. Alagirisamy were appointed as Additional Directors of the Company.
2013
  • The company name was changed to Lotus Eye Hospital and Institute Ltd.
2014
  • Lotus Eye Hospital And Institute Mulanthuruthy, Ernakulam District was launched.
2016
  • Lotus Eye Hospital & Institute Ltd. launched Kerala's First ReLEx SMILE The Most Advanced Laser Vision Correction.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
. THOMAS SANTOSHBuy124682123.9401 Sept 2025
. VRAMATH FINANCIAL SERVICES PVT LTDBuy11326958.0718 Mar 2025
. VRAMATH FINANCIAL SERVICES PVT LTDBuy20040980.620 Aug 2024
. VRAMATH FINANCIAL SERVICES PVT LTDBuy20159074.1113 Aug 2024
NK SECURITIES RESEARCH PRIVATE LIMITEDSell12656676.5713 Aug 2024
NK SECURITIES RESEARCH PRIVATE LIMITEDBuy12656676.4613 Aug 2024
. VRAMATH FINANCIAL SERVICES PVT LTDSell20159077.1113 Aug 2024
. VRAMATH FINANCIAL SERVICES PVT LTDSell3132868.9412 Jul 2024
. VRAMATH FINANCIAL SERVICES PVT LTDBuy13132865.2712 Jul 2024
RAJEEV CHOUDHARYBuy12000066.211 Mar 2024

Read More

Lotus Eye Hospital & Institute Ltd News

Lotus Eye Hospital Board to Consider NSE Delisting

Lotus Eye Hospital and Institute Limited has scheduled a board meeting for March 17, 2026, to consider voluntary delisting from NSE while maintaining BSE listing under SEBI regulations.

12 Mar 2026

co actions results

Lotus Eye Hospital Fined Rs 2.17 Lakh by BSE, NSE

Lotus Eye Hospital And Institute Limited faces Rs 2,17,120 fine each from BSE and NSE for non-compliance with SEBI LODR Regulation 17(1A). Company has rectified the violation through shareholder approval.

04 Mar 2026

stocks

Lotus Eye Hospital Promoter Share Transfer Disclosed

Sangeetha Sundaramoorthy acquired 14,28,571 shares from Kavetha Sundaramoorthy at Rs.70 per share, increasing stake from 28.14% to 35.01% in the eye care company.

02 Mar 2026

co actions results

Lotus Eye Hospital Reports Q3FY26 Loss of ₹26.07 Lakhs

Lotus Eye Hospital posted a net loss of ₹26.07 lakhs in Q3FY26 despite 10.64% revenue growth to ₹1,354.96 lakhs. Nine-month performance remained positive with ₹39.99 lakhs profit.

11 Feb 2026

co actions results

Lotus Eye Hospital CS M Achuth Menon Resigns

Lotus Eye Hospital announces resignation of Company Secretary & Compliance Officer M Achuth Menon due to personal reasons, effective February 12, 2026.

11 Feb 2026

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800